Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases

By Iersel Liselot  

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 1891-1898

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer

By Magge D.   Zureikat A.   Bartlett D.   Holtzman M.   Choudry H.   Beumer J.   Pingpank J.   Holleran J.   Strychor S.   Cunningham D.   Jones H.   Zeh H.  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2180-2187

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic Antitumor Effects of Histamine Plus Melphalan in Isolated Hepatic Perfusion for Liver Metastases

By Brunstein Flavia   Eggermont Alexander   Wiel-Ambagtsheer Gisela   Tiel Sandra   Rens Joost   Hagen Timo  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 795-801

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer

By Zeh Herbert   Brown Charles   Holtzman Matthew   Egorin Merrill   Holleran Julianne   Potter Douglas   Bartlett David  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 385-394

Springer Publishing Company

Access to resources Recommend Favorite

Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease

By Mocellin Simone   Pilati Pierluigi   Pian Pierpaolo   Forlin Marco   Corazzina Susanna   Rossi Carlo   Innocente Federico   Ori Carlo   Casara Dario   Ujka Francesca   Nitti Donato   Lise Mario  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 802-809

Springer Publishing Company

Access to resources Recommend Favorite